QSAR Modeling of a Novel Series of Methoxylated Chalcones as Antioxidant Agents Against Gram-Positive Bacteria Staphylococcus aureus

Year : 2025 | Volume : 03 | Issue : 01 | Page : 28 34
    By

    Neerja Shukla,

  • Shashikant Verma,

  1. Assistant Professor, Department of Chemistry, Nari Shiksha Niketan P.G. College, Mona Chandrawati Gupta Marg, Kaiserbagh, Lucknow, Uttar Pradesh, India
  2. Research Scholar, Department of Chemistry, Nari Shiksha Niketan P.G. College, Mona Chandrawati Gupta Marg, Kaiserbagh, Lucknow, Uttar Pradesh, India

Abstract

Background: Chalcones are aromatic ketones belonging to the flavonoid family. They are plant-based compounds and are widely found in nature. For centuries, these bioactive molecules have been utilized in various traditional medicines for the treatment of several ailments. Chalcones have antibacterial, antiviral, antimalarial, antifungal, antioxidant, and antileishmanial properties. They are also used to treat inflammation and cancer. Chalcones act as angiogenesis inhibitors, an important factor in cancer progression and metastasis. Method: QSAR analysis is done on a series of seventeen chalcones derivatives (1–16) using various physicochemical parameters. The study reveals that parameters, such as connectivity indices (χ5, χ6), ADME descriptors, molecular weight (MW), molar refractivity (MR), density (D), and LogP showed significant correlations with biological activity. The best results are obtained by performing multiple regression analyses with different models with strong R-squared values indicating robust predictive performance. Result: A combination of various descriptors, such as MR, MW, Pz, D, ADMET (LogS), and connectivity Indices (χ1–χ6) have been found to be best for the significant modeling of the anti-bacterial activity. QSAR model pIC50 = 3.374+ (–0.4484) χ5+ (0.5824) χ + (–0.2395) ADMET (LogS) optimized with empirical parameters with good statistical quality (R = 0.66, R2 = 0.44) was found to be the best model. Conclusion: The ADME solubility level reflects a molecule’s aqueous solubility, which can be predicted using molecular descriptors like the number of hydrogen bond donors and acceptors, dipole moment, rotatable bond count, and surface area. These factors are crucial in determining the solubility of the various organic compounds. Increased solubility has been shown to improve the antimicrobacterial activity. The positive sign of the connectivity indices implies that better better-designed drug can be obtained if there is an increase in the branching.

Keywords: QSAR modeling, methoxylated chalcones, Staphylococcus aureus, Gram-positive bacteria, ADME

[This article belongs to International Journal of Biochemistry and Biomolecule Research ]

How to cite this article:
Neerja Shukla, Shashikant Verma. QSAR Modeling of a Novel Series of Methoxylated Chalcones as Antioxidant Agents Against Gram-Positive Bacteria Staphylococcus aureus. International Journal of Biochemistry and Biomolecule Research. 2025; 03(01):28-34.
How to cite this URL:
Neerja Shukla, Shashikant Verma. QSAR Modeling of a Novel Series of Methoxylated Chalcones as Antioxidant Agents Against Gram-Positive Bacteria Staphylococcus aureus. International Journal of Biochemistry and Biomolecule Research. 2025; 03(01):28-34. Available from: https://journals.stmjournals.com/ijbbr/article=2025/view=196853


Browse Figures

References

  1. Chopra I, Schofield C, Everett M, O’Neill A, Miller K, Wilcox M, et al. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect Dis. 2008;8(2):133–139. doi:10.1016/S1473-3099(08)70018-
  2. Avila HP, Smânia Ede F, Monache FD, Smânia A Jr. Structure-activity relationship of antibacterial chalcones. Bioorg Med Chem. 2008;16(22):9790–9794. doi:10.1016/j.bmc.2008.09.064.
  3. Cheng JH, Hung CF, Yang SC, Wang JP, Won SJ, Lin CN. Synthesis and cytotoxic, anti-inflammatory, and anti-oxidant activities of 2′, 5′-dialkoxylchalcones as cancer chemopreventive agents. Bioorg Med Chem. 2008;16(15):7270–7276. doi:10.1016/j.bmc.2008.06.031.
  4. Katsori AM, Hadjipavlou-Litina D. Chalcones in cancer: understanding their role in terms of QSAR. Curr Med Chem. 2009;16(9):1062–1081. doi:10.2174/092986709787581798.
  5. Murakami S, Kijima H, Isobe Y, Muramatsu M, Aihara H, Otomo S, et al. Inhibition of gastric H+, K(+)-ATPase by chalcone derivatives, xanthoangelol and 4-hydroxyderricin, from Angelica keiskei Koidzumi. J Pharm Pharmacol. 1990;42(10):723–726. doi:10.1111/j.2042-7158.1990.tb06568.x.
  6. Viana GS, Bandeira MA, Matos FJ. Analgesic and anti-inflammatory effects of chalcones isolated from Myracrodruon urundeuva allemão. Phytomedicine. 2003;10(2–3):189–195. doi:10.1078/094471103321659924.
  7. Wu JH, Wang XH, Yi YH, Lee KH. Anti-AIDS agents 54. A potent anti-HIV chalcone and flavonoids from genus Desmos. Bioorg Med Chem Lett. 2003;13(10):1813–1815. doi:10.1016/s0960-894x(03)00197-5.
  8. Liu M, Wilairat P, Go ML. Antimalarial alkoxylated and hydroxylated chalcones structure-activity relationship analysis. J Med Chem. 2001;44(25):4443–4452. doi:10.1021/jm0101747.
  9. Sivakumar PM, Seenivasan SP, Kumar V, Doble M. Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives. Bioorg Med Chem Lett. 2007;17(6):1695–1700. doi:10.1016/j.bmcl.2006.12.112.
  10. Chen ZH, Zheng CJ, Sun LP, Piao HR. Synthesis of new chalcone derivatives containing a rhodanine-3-acetic acid moiety with potential anti-bacterial activity. Eur J Med Chem. 2010;45(12):5739–5743. doi:10.1016/j.ejmech.2010.09.031.
  11. Bandgar BP, Gawande SS, Bodade RG, Totre JV, Khobragade CN. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bioorg Med Chem. 2010;18(3):1364–1370. doi:10.1016/j.bmc.2009.11.066.
  12. Ballell L, Field RA, Duncan K, Young RJ. New small-molecule synthetic antimycobacterials. Antimicrob Agents Chemother. 2005;49(6):2153–2163. doi:10.1128/AAC.49.6.2153-2163.2005. Erratum in: Antimicrob Agents Chemother. 2007 May;51(5):1888.
  13. Tantapakul C, Promgool T, Kanokmedhakul K, Soytong K, Song J, Hadsadee S, et al. Bioactive xanthoquinodins and epipolythiodioxopiperazines from Chaetomium globosum 7s-1, an endophytic fungus isolated from Rhapis cochinchinensis (Lour.) Mart Nat Prod Res. 2020;34(4):494–502.
  14. Herencia F, Ferrándiz ML, Ubeda A, Domínguez JN, Charris JE, Lobo GM, et al. Synthesis and anti-inflammatory activity of chalcone derivatives. Bioorg Med Chem Lett. 1998;8(10):1169–1174. doi:10.1016/s0960-894x(98)00179-6 From NLM.
  15. Scanga CA, Mohan VP, Tanaka K, Alland D, Flynn JL, Chan J. The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect Immun. 2001;69(12):7711–7717.
  16. Kamble VM, Hatnapure GD, Keche AP, Birajdar S, Patil SG, Tale RH, et al. Sintesis and biological evaluation of a novel series of methoxylated chalcones as antioxidant and anti-microbial agents. J Chem Pharm Res. 2011;3(6):639–648.
  17. Shukla N, Srivastava AK. Exploring Qsar Analysis of Cyclohexanamine Class of Human Serotonin Transporters (Hsert) Inhibitory Activities Using Physicochemical Parameters. Oxidation Commun. 2013;36(1):133–142.
  18. Srivastava AK, Shukla N. QSAR based modeling on a series of lactam fused chroman derivatives as selective 5-HT transporters. J Saudi Chem Soc. 2012;16(4):405–412.
  19. Shukla N. QSAR studies on a series of 9-THC analogues as cannabinoid receptor modulators. Int J Student Res Technol Manag. 2014;2:29–36.
  20. Abdullahi M, Adeniji SE, Arthur DE, Musa S. Quantitative structure-activity relationship (QSAR) modelling study of some novel carboxamide series as new anti-tubercular agents. Bull National Res Centre. 2020;44(1):136.
  21. Shukla N, Sharma B. Quantitative structure-activity relationship (QSAR) modelling of indomethacin derivatives using regression analysis. Curr Med Chem. 2024;31(40):6722–6732.
  22. Srivastava AK, Srivastava A, Shukla N. QSAR study on TIE-2 inhibitors: dominating role of topological parameters. Oxidation Commun. 2013;36(1):143–155.
  23. Yadav AR, Mohite SK. ADME analysis of phytochemical constituents of Psidium guajava.
  24. Srivastava AK, Shukla N. Quantitative structure activity relationship (QSAR) studies on a series of imidazole derivatives as novel ORL1 receptor antagonists. J Saudi Chem Soc. 2013;17(3):321–328.
  25. Sefiddashti FM, Asadpour S, Haddadi H, Nasab SG. QSAR analysis of pyrimidine derivatives as VEGFR-2 receptor inhibitors to inhibit cancer using multiple linear regression and artificial neural network. Res Pharm Sci. 2021;16(6):596–611.
  26. Srivastava AK, Shukla N. QSAR-based modelling on a novel series of pyrimidine-4-carboxamides as antagonists of the human A1 receptor. Oxidation Commun. 2012;35(2):423–437.
  27. Shukla N, Srivastava AK. Qsar-Based Modelling on A Novel Series of 2-Chlorobenzaniide Derivatives as Potent P2x (7) Receptor Antagonist. Oxidation Commun. 2014;37(1):290–300.
  28. Sahu R, Shukla N. In-silico analysis of different plant protein and their essential compound with sulfonylurea binding protein of β-cells of homo sapiens for curing diabetes mellitus type ii disease. Euro Chem Bull. 2014;3(6):568–576.
  29. Srivastava AK, Shukla N, Pandey A, Srivastava A. QSAR based modeling on a series of α-hydroxy amides as a novel class of bradykinin B1 selective antagonists. J Saudi Chem Soc. 2011;15(3):215–220.
  30. Chen XQ, Cho SJ, Li Y, Venkatesh S. Prediction of aqueous solubility of organic compounds using a quantitative structure–property relationship. J Pharm Sci. 2002;91(8):1838–1852.
  31. Tangallapally RP, Yendapally R, Lee RE, Hevener K, Jones VC, Lenaerts AJ, et al. Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents. J Med Chem. 2004;47(21):5276–5283.
Regular Issue Subscription Original Research
Volume 03
Issue 01
Received 03/12/2024
Accepted 23/01/2025
Published 03/02/2025
Publication Time 62 Days
282

Login


My IP

PlumX Metrics